Mafenide Acetate

CHEMBL1201161 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
246.3 g/mol
LogP
Phase
4

An acetate salt form of mafenide, a topical sulfonamide antibiotic used to prevent and control bacterial infections in second- and third-degree burn wounds by penetrating wound tissue.

Masse moléculaire

246,2900 g/mol

TPSA

132,00 Ų

Mécanisme d'action

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mécanisme

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(=O)O.NCc1ccc(S(N)(=O)=O)cc1

InChI

InChI=1S/C7H10N2O2S.C2H4O2/c8-5-6-1-3-7(4-2-6)12(9,10)11;1-2(3)4/h1-4H,5,8H2,(H2,9,10,11);1H3,(H,3,4)

Molecular Formula

C9H14N2O4S

HBD / HBA

3 / 6

Liaisons Rotatives

2

Atomes Lourds

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

An acetate salt form of mafenide, a topical sulfonamide antibiotic used to prevent and control bacterial infections in second- and third-degree burn wounds by penetrating wound tissue.

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Yes, Mafenide Acetate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201161. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 25590. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.